Axonyx regains compliance with Nasdaq minimum bid price rule

By Angela McDaniels

Seattle, March 8 - Axonyx Inc. has regained compliance with the Nasdaq Stock Market's $1.00 per share minimum bid price rule, and the company's stock will continue to be listed on the Nasdaq Capital Market, according to a company news release.

The company's (Nasdaq: AXYX) stock closed at $1.01 on Wednesday, down from $1.05 on Tuesday.

Axonyx is a New York-based biopharmaceutical company that acquires and develops proprietary pharmaceutical compounds for the treatment of central nervous system disorders.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.